Feature Channels:
Dermatology
Filters:
MedicineChannels:All Journal News, Cell Biology, Dermatology, Genetics, Microbiome, Nature (journal), Local - Maryland Microbiome, human microbiome, Gene, DNA, Cancer, GUT, Vagina, skin |
A new study of the human microbiome has uncovered millions of previously unknown genes from microbial communities in the human gut, skin, mouth, and vaginal microbiome, allowing for new insights into the role these microbes play in human health and disease. |
Embargo expired: 20-Sep-2017 1:00 PM EDT
Released: 19-Sep-2017 1:05 PM EDT
University of Maryland School of Medicine |
MedicineScienceChannels:melanoma cells, dissemination |
A study conducted at The Wistar Institute has led to the identification of a slowly proliferating and highly invasive melanoma cell subpopulation, characterized by production of a protein associated with invasive behavior. |
Released: 20-Sep-2017 11:05 AM EDT
Wistar Institute |
MedicineChannels:Harold C. Simmons Comprehensive Cancer Center, Ut Southwestern, CPRIT Awards, Cancer Research, Breast Cancer |
The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded UT Southwestern researchers more than $34 million for cancer research and faculty recruitment, including support for programs in pancreatic cancer, lung cancer, breast cancer, and melanoma. |
Released: 19-Sep-2017 1:05 PM EDT
UT Southwestern Medical Center |
ScienceChannels:Melanoma, Resistance, cross-talk |
In a multi-institutional collaborative study, scientists at The Wistar Institute and the Medical University of Vienna, Austria, have identified the role of tumor-infiltrating or tumor-associated B-cells (“TABs”) in melanoma progression and resistance to targeted therapy. |
Released: 19-Sep-2017 12:05 PM EDT
Wistar Institute |
MedicineChannels:American Academy Of Dermatology, Dermatology, Dermatologist, Dermatology A to Z, board-certified dermatologist, AAD, Ticks, tick removal, how to remove a tick, tick prevention, how to prevent tick bites, Tick Bite, Tick Bites, Lyme Disease, Rocky Mountain Spotted Fever, tick-borne disease, tick disease, Bug Bites |
As tick populations grow and spread across the country, their prevalence is increasing the public’s risk for some troubling diseases. Of these diseases, say dermatologists from the American Academy of Dermatology, Lyme disease, Rocky Mountain spotted fever, Powassan virus and alpha-gal syndrome—a mysterious red meat allergy—are among the most serious. |
Released: 19-Sep-2017 10:05 AM EDT
American Academy of Dermatology |
ScienceChannels: |
A UCLA study has uncovered the mechanisms by which treatment-resistant melanoma become vulnerable to cessation of a class of drugs called MAP kinase (MAPK)-targeted inhibitors. By identifying these mechanisms, the scientists discovered that therapeutic benefits for patients could derive from a one-two punch of a drug holiday of MAPK inhibitors followed by a class of drugs called DNA repair inhibitors. |
Released: 18-Sep-2017 3:00 PM EDT
University of California, Los Angeles (UCLA), Health Sciences |
MedicineChannels:Cancer, Melanoma, Immunotherapy, Lymphangiogenesis, checkpoint inhibitors |
Lymphatic vessels, often blamed for enabling cancer cells to spread from a primary location to many other sites, have a flip side. A team of researchers found that in patients being treated with checkpoint inhibitors, lymphangiogenesis boosts the immune system’s primary anti-cancer tool, T cells, enabling them to infiltrate tumors and kill cancer cells. |
Embargo expired: 13-Sep-2017 2:00 PM EDT
Released: 11-Sep-2017 1:05 PM EDT
University of Chicago Medical Center |
MedicineChannels:Biotech, Blood Disorders, Bone Health, Cancer, Cell Biology, Chemistry, Children's Health, Complementary Medicine, Dermatology, Genetics, Healthcare, Immunology, Drug Resistance, Infectious Diseases, Kidney Disease, Men's Health, Mental Health, Military Health, Mindfulness, Neuro, Nursing, Nutrition, OBGYN, Oral Health, Pain, Personalized Medicine, Pharmaceuticals, |
Checking Your Neck, Colon Cancer Screening, New Microfluidic Device, and More in the Cancer News SourceClick here to go directly to the Cancer News Source |
Released: 11-Sep-2017 3:25 PM EDT
Newswise |
MedicineChannels:All Journal News, Cancer, Dermatology, Immunology, NEJM, Local - New York, Local - New York Metro, Medical Meetings Cancer, Melanoma, High Risk, Immunotheapy, drug, nivolumab, Ipilimumab, Disease |
The immunotherapy drug nivolumab is safer and more effective than ipilimumab—the current standard of care—in treating patients with resected stage III and stage IV melanoma. |
Embargo expired: 10-Sep-2017 6:05 PM EDT
Released: 10-Sep-2017 6:05 PM EDT
NYU Langone Health |
MedicineChannels: |
A UCLA-led study of changes in gene activity in BRAF-mutated melanoma suggests these epigenomic alterations are not random but can explain how tumors are already developing resistance as they shrink in response to treatment with a powerful class of drugs called MAP kinase (MAPK)-targeted inhibitors. |
Released: 8-Sep-2017 5:00 PM EDT
University of California, Los Angeles (UCLA), Health Sciences |